SCHEMBL4431999

SCHEMBL4431999

CC(C)(C)OC(=O)N(c1ccc(C(=O)C2CC2)cc1N)C1CCCNC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
CYP2D6 P10635 1/20 0.34
KMT2A Q03164 1/20 0.34
KCNH2 Q12809 5/20 0.33
PCSK9 Q8NBP7 8/20 0.33
RPLP1 P05386 4/20 0.33
RPLP0 P05388 4/20 0.33
RPS17 P08708 4/20 0.33
RPSA P08865 4/20 0.33
RPS2 P15880 4/20 0.33
RPL35A P18077 4/20 0.33
RPL7 P18124 4/20 0.33
RPL17 P18621 4/20 0.33
RPS4Y1 P22090 4/20 0.33
RPS3 P23396 4/20 0.33
RPS12 P25398 4/20 0.33
RPL13 P26373 4/20 0.33
RPL10 P27635 4/20 0.33
RPL12 P30050 4/20 0.33
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433912 0.90 FLT3 (0.35) KCNH2PCSK9RPLP1RPLP0RPS17
SCHEMBL4438021 0.87 KCNH2 (0.37) MEN1KMT2AKCNH2PCSK9RPLP1
SCHEMBL4443673 0.86 RPLP1 (0.34) CYP2D6KCNH2PCSK9RPLP1RPLP0
SCHEMBL4436874 0.85 HTT (0.37) MEN1CYP2D6KMT2AGAAMAPT
SCHEMBL4437552 0.85 SLC6A2 (0.39) MEN1CYP2D6KMT2AKCNH2SLC6A2
SCHEMBL4445222 0.84 RPLP1 (0.40) MEN1KMT2AKCNH2PCSK9RPLP1
SCHEMBL4434418 0.80 RPLP1 (0.34) CYP2D6KCNH2PCSK9RPLP1RPLP0
SCHEMBL4436048 0.79 RPLP1 (0.36) KCNH2PCSK9RPLP1RPLP0RPS17
SCHEMBL3410670 0.79 RPLP1 (0.36) KCNH2PCSK9RPLP1RPLP0RPS17
SCHEMBL7455407 0.79 GPR119 (0.36) CYP2D6KCNH2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed